|
US20090137416A1
(en)
|
2001-01-16 |
2009-05-28 |
Regeneron Pharmaceuticals, Inc. |
Isolating Cells Expressing Secreted Proteins
|
|
US6919183B2
(en)
*
|
2001-01-16 |
2005-07-19 |
Regeneron Pharmaceuticals, Inc. |
Isolating cells expressing secreted proteins
|
|
GB0118337D0
(en)
*
|
2001-07-27 |
2001-09-19 |
Lonza Biologics Plc |
Method for selecting antibody expressing cells
|
|
JP2005526517A
(ja)
*
|
2002-05-22 |
2005-09-08 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
分泌性ポリペプチドの検出
|
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
|
US7771969B2
(en)
|
2003-08-20 |
2010-08-10 |
Celltech R&D Limited |
Methods for obtaining antibodies
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
AR060358A1
(es)
|
2006-04-06 |
2008-06-11 |
Novartis Vaccines & Diagnostic |
Quinazolinas para la inhibicion de pdk 1
|
|
EP2021795A4
(en)
|
2006-05-04 |
2009-05-13 |
Abmaxis Inc |
CROSS SPECIES AND MULTI-SPECIAL PRESENTATION SYSTEMS
|
|
EP2027273B1
(en)
|
2006-05-17 |
2016-04-13 |
F. Hoffmann-La Roche AG |
Polypeptide producing cells
|
|
DK2102239T3
(da)
*
|
2006-11-30 |
2012-05-29 |
Res Dev Foundation |
Forbedrede immunoglobulin-biblioteker
|
|
US20090075378A1
(en)
*
|
2007-02-20 |
2009-03-19 |
Anaptysbio, Inc. |
Somatic hypermutation systems
|
|
EP2617827A1
(en)
|
2007-03-26 |
2013-07-24 |
Celexion, LLC |
Method for displaying engineered proteins on a cell surface
|
|
US12529164B2
(en)
|
2007-09-14 |
2026-01-20 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
EP3124497B1
(en)
|
2007-09-14 |
2020-04-15 |
Adimab, LLC |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US8637435B2
(en)
*
|
2007-11-16 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Eukaryotic cell display systems
|
|
EP2240475B1
(en)
|
2007-12-20 |
2013-09-25 |
Novartis AG |
Thiazole derivatives used as pi 3 kinase inhibitors
|
|
WO2009103753A1
(en)
*
|
2008-02-20 |
2009-08-27 |
Ablynx Nv |
Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods
|
|
JP5731827B2
(ja)
|
2008-03-03 |
2015-06-10 |
グライコフィ， インコーポレイテッド |
下等真核生物中での組換えタンパク質の表面ディスプレイ
|
|
US8067339B2
(en)
*
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
|
WO2010064748A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Korea Research Institute Of Bioscience And Biotechnology |
Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
|
|
US8409838B2
(en)
|
2009-06-02 |
2013-04-02 |
Regeneron Pharmaceuticals, Inc. |
Fucosylation-deficient cells
|
|
US8293753B2
(en)
|
2009-07-02 |
2012-10-23 |
Novartis Ag |
Substituted 2-carboxamide cycloamino ureas
|
|
US8278873B2
(en)
*
|
2009-09-10 |
2012-10-02 |
Syntheon, Llc |
Surgical sterilizer with integrated battery charging device
|
|
CA2789446A1
(en)
*
|
2010-02-12 |
2011-08-18 |
Oncomed Pharmaceuticals, Inc. |
Methods for identifying and isolating cells expressing a polypeptide
|
|
EP2390661B1
(en)
*
|
2010-05-02 |
2015-06-24 |
Miltenyi Biotec GmbH |
An anchoring/capturing means for selecting or analyzing a CHO cell according to a product secreted by the CHO cell
|
|
US9242014B2
(en)
|
2010-06-15 |
2016-01-26 |
The Regents Of The University Of California |
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof
|
|
KR102318383B1
(ko)
|
2010-07-16 |
2021-10-27 |
아디맵 엘엘씨 |
항체 라이브러리
|
|
AR082418A1
(es)
|
2010-08-02 |
2012-12-05 |
Novartis Ag |
Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
|
|
US8986956B2
(en)
|
2010-11-04 |
2015-03-24 |
Korea Research Institute Of Bioscience And Biotechnology |
Method for producing human epidermal growth factor in large volume from yeast
|
|
IL210093A0
(en)
*
|
2010-12-19 |
2011-06-30 |
David Helman |
Membrane bound reporter molecules and their use in cell sorting
|
|
JP2014504503A
(ja)
|
2010-12-28 |
2014-02-24 |
ゾーマ テクノロジー リミテッド |
Ｐｄｚドメインを用いた細胞表面提示
|
|
EP3604339B1
(en)
|
2011-01-14 |
2021-03-10 |
The Regents Of The University Of California |
Therapeutic antibodies against ror-1 protein and methods for use of same
|
|
MX343706B
(es)
|
2011-01-31 |
2016-11-18 |
Novartis Ag |
Derivados heterocíclicos novedosos.
|
|
CN102680679B
(zh)
*
|
2011-03-15 |
2014-08-27 |
中国科学院上海生命科学研究院 |
检测单细胞特异性抗体分泌的细胞微孔芯片及其制备方法
|
|
PT2771342T
(pt)
|
2011-10-28 |
2016-08-17 |
Novartis Ag |
Derivados de purina e o seu uso no tratamento de doença
|
|
EP2847368B1
(en)
|
2012-05-11 |
2020-08-19 |
Merck Sharp & Dohme Corp. |
Surface anchored light chain bait antibody display system
|
|
WO2013173283A1
(en)
|
2012-05-16 |
2013-11-21 |
Novartis Ag |
Dosage regimen for a pi-3 kinase inhibitor
|
|
TW201823460A
(zh)
|
2012-05-29 |
2018-07-01 |
美商再生元醫藥公司 |
生產細胞株增強子
|
|
ES2702315T3
(es)
|
2012-08-24 |
2019-02-28 |
Univ California |
Anticuerpos y vacunas para su uso en tratar cánceres ROR1 e inhibir metástasis
|
|
TW202423993A
(zh)
*
|
2012-11-14 |
2024-06-16 |
美商再生元醫藥公司 |
重組細胞表面捕捉蛋白質
|
|
TWI635098B
(zh)
|
2013-02-01 |
2018-09-11 |
再生元醫藥公司 |
含嵌合恆定區之抗體
|
|
US9353163B2
(en)
|
2013-03-14 |
2016-05-31 |
Regeneron Pharmaceuticals, Inc. |
Apelin fusion proteins and uses thereof
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
GB201316644D0
(en)
|
2013-09-19 |
2013-11-06 |
Kymab Ltd |
Expression vector production & High-Throughput cell screening
|
|
KR102243980B1
(ko)
|
2013-10-11 |
2021-04-26 |
리제너론 파마슈티칼스 인코포레이티드 |
대사적으로 최적화된 세포 배양
|
|
CN105979947A
(zh)
|
2013-12-06 |
2016-09-28 |
诺华股份有限公司 |
α-同工型选择性磷脂酰肌醇3-激酶抑制剂的剂量方案
|
|
AR102333A1
(es)
|
2014-08-19 |
2017-02-22 |
Regeneron Pharma |
Selectividad eficiente de proteínas recombinadas
|
|
TWI870789B
(zh)
|
2015-08-04 |
2025-01-21 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
|
RU2018119085A
(ru)
|
2015-11-02 |
2019-12-04 |
Новартис Аг |
Схема введения ингибитора фосфатидилинозитол-3-киназы
|
|
WO2017132701A1
(en)
*
|
2016-01-31 |
2017-08-03 |
Shuang Zhang |
Method for screening antibodies
|
|
EP4414484A3
(en)
*
|
2016-02-04 |
2025-01-15 |
Trianni, Inc. |
Enhanced production of immunoglobulins
|
|
WO2017203051A1
(en)
|
2016-05-26 |
2017-11-30 |
University College Cork - National University Of Ireland, Cork |
An engineered gram positive bacterium
|
|
US20200317738A1
(en)
|
2016-05-26 |
2020-10-08 |
University College Cork - National University Of Ireland, Cork |
Methods for increasing proliferation of mammalian cells
|
|
TWI767915B
(zh)
|
2016-06-27 |
2022-06-21 |
加州大學董事會 |
Ror-1與btk拮抗劑的組合
|
|
WO2018041740A1
(en)
|
2016-09-01 |
2018-03-08 |
Bayer Pharma Aktiengesellschaft |
Non-covalent display system using fimgt/dsf
|
|
WO2018060833A1
(en)
|
2016-09-27 |
2018-04-05 |
Novartis Ag |
Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
|
|
CN109790214B
(zh)
|
2016-09-29 |
2022-09-06 |
豪夫迈·罗氏有限公司 |
用于选择产生多肽的细胞的改进方法
|
|
GB201703418D0
(en)
|
2017-03-03 |
2017-04-19 |
Ge Healthcare Bio Sciences Ab |
Method for cell line development
|
|
GB201704115D0
(en)
*
|
2017-03-15 |
2017-04-26 |
Oxford Genetics Ltd |
Method of selecting for antibodies
|
|
IL312457A
(en)
|
2017-03-24 |
2024-06-01 |
Lankenau Inst Medical Res |
Methods and compositions for inducible extracellular membrane trapping of monoclonal immunoglobulins secreted by hybridomas
|
|
EP3673044A1
(en)
|
2017-08-25 |
2020-07-01 |
University College Cork-National University of Ireland, Cork |
Bifidobacterium longum for treating obesity and weight management
|
|
US20200345051A1
(en)
|
2017-11-24 |
2020-11-05 |
University College Cork, National University Of Ireland, Cork |
A composition comprising a cohort of bacteria
|
|
EP3604507A1
(en)
|
2018-07-30 |
2020-02-05 |
University College Cork-National University of Ireland, Cork |
An omega-transaminase enzyme
|
|
WO2020056456A1
(en)
*
|
2018-09-17 |
2020-03-26 |
South Australian Health And Medical Research Institute Limited |
Methods for producing proteins
|
|
AU2020256225B9
(en)
*
|
2019-04-03 |
2025-04-10 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
|
|
EP3783012A1
(en)
|
2019-08-20 |
2021-02-24 |
Nuritas Limited |
An antimicrobial peptide
|
|
EP4218787A3
(en)
|
2019-08-20 |
2023-12-20 |
Nuritas Limited |
Peptides for treating muscle atrophy
|
|
JP2022553367A
(ja)
|
2019-10-22 |
2022-12-22 |
ニューリタス リミテッド |
非アルコール性脂肪肝の治療
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
CN117015710A
(zh)
*
|
2021-03-10 |
2023-11-07 |
索尼集团公司 |
生物粒子分析方法及用于生物粒子分析的试剂盒
|
|
EP4070670A1
(en)
|
2021-04-08 |
2022-10-12 |
University College Cork-National University of Ireland Cork |
Lacticaseibacillus paracasei em025-11 and uses thereof
|
|
JP2024514195A
(ja)
|
2021-04-14 |
2024-03-28 |
ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク |
脳血管イベントおよび神経障害の治療
|
|
US20240197827A1
(en)
|
2021-04-14 |
2024-06-20 |
University College Cork - National University Of Ireland, Cork |
Psg1 for use in the treatment of osteoarthritis
|
|
WO2023059803A1
(en)
|
2021-10-07 |
2023-04-13 |
Regeneron Pharmaceuticals, Inc. |
Ph meter calibration and correction
|
|
CA3230984A1
(en)
|
2021-10-07 |
2023-04-13 |
Ross BROWNE |
Systems and methods of ph modeling and control
|
|
CN119301236A
(zh)
|
2022-03-02 |
2025-01-10 |
瑞泽恩制药公司 |
用于抗体生产的生物反应器
|
|
CN120379687A
(zh)
|
2022-10-14 |
2025-07-25 |
爱尔兰国立科克大学 |
胎盘表达的蛋白用于治疗肌腱损伤
|
|
WO2025133254A2
(en)
|
2023-12-20 |
2025-06-26 |
Nuritas Limited |
Angiotensin-converting enzyme (ace) inhibiting peptides.
|
|
WO2025133189A1
(en)
|
2023-12-20 |
2025-06-26 |
Nuritas Limited |
Sleep promoting peptides and the use thereof
|
|
CN118006552A
(zh)
*
|
2024-04-09 |
2024-05-10 |
暨南大学 |
一种抗原特异性浆细胞的筛选方法及其应用
|
|
WO2026008665A1
(en)
|
2024-07-01 |
2026-01-08 |
Vib Vzw |
Binders of the pd-1•pd-l1 complex and their use
|